I take your point, but it was a no-brainer to raise on this ovcasion. In fact it was negligent not to imo. If I recall correctly, it was just before this that Justin (former CFO) was specifically asked in the Q&A after a webinar about plans to raise - and he muttered something about dtill having a few quarters of cash in the bank, but it was quite clear the thought hadn’t even crossed his mind despite the company readying to fund multiple expensive trials. We’ve been getting slaughtered since this point.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-165
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $85.73M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 23.0¢ | $180.4K | 746.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 79748 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 22818 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |